Reference: BMJ 2013;346:f1363, published 21st March 2013
Date published: 22/03/2013 16:56
Summary
by: Devika Sennik
The authors of this article estimate the effect of the end of life criteria on the NHS in England and Wales since they were introduced in 2009. They quantify the impact of raising the cost effectiveness threshold for end of life drugs and find that the effect on other NHS services could be substantial.
